Shares of Solventum jumped Tuesday and led S&P 500 gainers intraday after medical device maker Thermo Fisher Scientific said it would acquire the company’s purification and filtration business for $4.

1 Other than for its operations in Belgium, France and Ireland, for which Thermo Fisher granted a binding offer to Solventum About Solventum At Solventum, we enable better, smarter, safer ...

Explore Thermo Fisher Scientific Inc.'s valuation, modest growth challenges, and recent M&A moves. Click for my updated look ...

Highly Complementary to Thermo Fisher’s Bioproduction Business and Strengthens Offering in the High Growth Bioprocessing Market Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher ...

(Reuters) -Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration business for about $4.1 billion, sending the latter's shares up ...

Thermo Fisher said it is paying about $4.1 billion in cash for the business. The Journal reported in October that Solventum, the healthcare company spun off from 3M last year, had retained bankers ...

Thermo Fisher Scientific is growing its lab equipment empire with a deal to buy 3M’s former purification and filtration business for $4.1 billion. Waltham-based Thermo is buying the business ...

"The sale of the Purification & Filtration business is part of phase three of our transformation plan and follows a thorough analysis of the value and strategic alignment of our businesses," said ...